Announcing the LIVE 2025 Promotion Name: A Tribute to Professor Uğur Şahin
As we begin our exciting two-year journey in the Leading International Vaccinology Education for Innovation (LIVE_Innov) program, we, the students of the 2025–2027 Master LIVE M1 class, are thrilled to announce that we have chosen to honor Professor Uğur Şahin by naming our promotion after him. This decision is a heartfelt tribute to his incredible contributions to the field of vaccinology, his groundbreaking work in mRNA technology, and his inspiring leadership. His impact on the world of science and health has profoundly shaped the future, and it is an honor for us to carry forward his legacy. Professor Şahin is a pioneer in the field of immunology and biotechnology, with his most notable achievement being the development of the world’s first authorized mRNA-based COVID-19 vaccine, in December 2020: the BNT162b2 vaccine by Pfizer-BioNTech. As the co-founder and CEO of BioNTech, he led the charge in harnessing the power of mRNA technology, not only to combat the global pandemic but also to pave the way for future vaccines and treatments for other diseases, including cancer. His work has revolutionized our understanding of how we can use the body’s immune system to fight disease, and his vision for the future of medicine continues to inspire scientists around the globe.
Professor Şahin’s career is marked by a series of remarkable milestones. His scientific innovations have earned him widespread recognition and numerous accolades such as Merit Award of the American Society of Clinical Oncology, Werner von Siemens Ring, German Cancer Award, the Order of Merit of the Federal Republic of Germany, the Mustafa Prize (2019), Prix Jeantet-Collen for Translational Medicine (2022), including being named one of the most influential figures in biotechnology. But beyond these achievements, it is his ability to turn scientific discoveries into practical solutions that has had a lasting impact on global health. His work exemplifies the intersection of cutting-edge research and real-world application, a core value we hold dear in the LIVE_Innov program. In addition to his scientific accomplishments, Professor Şahin has consistently championed the importance of collaboration, inclusivity, and equitable access to healthcare. His efforts to ensure that vaccines and treatments reach people around the world, especially those in underserved areas, reflect his commitment to making a meaningful difference in global health. His advocacy for international cooperation in addressing health crises serves as a powerful reminder that science must serve the greater good, and that our work as future vaccinologists should always aim to benefit humanity as a whole. As we honor Professor Şahin, we also embrace the values that have driven his success: innovation, leadership, and a deep commitment to global health. By adopting his name for our promotion, we aspire to follow in his footsteps and make our own contributions to the world of science. We aim to push the boundaries of what’s possible, embrace collaboration, and ensure that our research can have a positive impact on the world.
In conclusion, it is with great pride and respect that we, the LIVE 2025–2027 Master Class, choose to adopt Professor Uğur Şahin’s name as the symbol of our promotion. We are inspired by his unwavering dedication to science and his remarkable achievements, and we are determined to carry his legacy forward. Together, we will strive to embody his values of perseverance, innovation, and global impact as we continue our journey in vaccinology and work towards improving the health and well-being of people around the world.
2025.09.29 – Md Tanjim Hasan, Master LIVE M1 Student
A Tribute to Professor Uğur Şahin
Announcing the LIVE 2025 Promotion Name: A Tribute to Professor Uğur Şahin
As we begin our exciting two-year journey in the Leading International Vaccinology Education for Innovation (LIVE_Innov) program, we, the students of the 2025–2027 Master LIVE M1 class, are thrilled to announce that we have chosen to honor Professor Uğur Şahin by naming our promotion after him. This decision is a heartfelt tribute to his incredible contributions to the field of vaccinology, his groundbreaking work in mRNA technology, and his inspiring leadership. His impact on the world of science and health has profoundly shaped the future, and it is an honor for us to carry forward his legacy. Professor Şahin is a pioneer in the field of immunology and biotechnology, with his most notable achievement being the development of the world’s first authorized mRNA-based COVID-19 vaccine, in December 2020: the BNT162b2 vaccine by Pfizer-BioNTech. As the co-founder and CEO of BioNTech, he led the charge in harnessing the power of mRNA technology, not only to combat the global pandemic but also to pave the way for future vaccines and treatments for other diseases, including cancer. His work has revolutionized our understanding of how we can use the body’s immune system to fight disease, and his vision for the future of medicine continues to inspire scientists around the globe.
Professor Şahin’s career is marked by a series of remarkable milestones. His scientific innovations have earned him widespread recognition and numerous accolades such as Merit Award of the American Society of Clinical Oncology, Werner von Siemens Ring, German Cancer Award, the Order of Merit of the Federal Republic of Germany, the Mustafa Prize (2019), Prix Jeantet-Collen for Translational Medicine (2022), including being named one of the most influential figures in biotechnology. But beyond these achievements, it is his ability to turn scientific discoveries into practical solutions that has had a lasting impact on global health. His work exemplifies the intersection of cutting-edge research and real-world application, a core value we hold dear in the LIVE_Innov program.
In addition to his scientific accomplishments, Professor Şahin has consistently championed the importance of collaboration, inclusivity, and equitable access to healthcare. His efforts to ensure that vaccines and treatments reach people around the world, especially those in underserved areas, reflect his commitment to making a meaningful difference in global health. His advocacy for international cooperation in addressing health crises serves as a powerful reminder that science must serve the greater good, and that our work as future vaccinologists should always aim to benefit humanity as a whole.
As we honor Professor Şahin, we also embrace the values that have driven his success: innovation, leadership, and a deep commitment to global health. By adopting his name for our promotion, we aspire to follow in his footsteps and make our own contributions to the world of science. We aim to push the boundaries of what’s possible, embrace collaboration, and ensure that our research can have a positive impact on the world.
In conclusion, it is with great pride and respect that we, the LIVE 2025–2027 Master Class, choose to adopt Professor Uğur Şahin’s name as the symbol of our promotion. We are inspired by his unwavering dedication to science and his remarkable achievements, and we are determined to carry his legacy forward. Together, we will strive to embody his values of perseverance, innovation, and global impact as we continue our journey in vaccinology and work towards improving the health and well-being of people around the world.
2025.09.29 – Md Tanjim Hasan,
Master LIVE M1 Student
Menu
Archives